Session 13: Treatment of HHT  

11 Jun 2017
10:05 am – 11:05 am  
Soderini Ballroom II, III

Session 13: Treatment of HHT  

Oral Presentations

10:05am – 10:20am

Long-term outcomes for radiosurgical management of brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia

Surgical treatment versus non-surgical treatment for brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: a retrospective multicenter consortium study

Tayebi Meybodi A, Kim H, Nelson J, Hetts S, Krings T, ter Brugge K, Faughnan M, Lawton M, and the Brain Vascular Malformation Consortium HHT Investigator Group

 

10:20am – 10:35am

Systemic to pulmonary arteriovenous malformations (SPAVM): a distinct entity from HHT PAVMS clinically, on imaging, and for embolization, with whole genome analysis

Mitchell S, Terry P, Ringel R, Sobreira N

 

10:35am – 10:50am

Progression of pulmonary arteriovenous malformations in children with hereditary hemorrhagic telangiectasia

Mowers KL, Sekarski L, White AJ, Grady RM

 

10:50am – 11:05am

Human endoglin as a potential new partner involved in platelet-endothelium interactions

Rossi E, Pericacho M, BachelotLoza C, Pidard D, Gaussem P, Poirault-Chassac S, Blanco FJ, Lang C, Gonzalez-Manchon C, Lopez-Novoa J-M, Smadja DM, Bernabeu C